HTLV-I Infection

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HTLV-I Infection trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT00001778

Evaluation of Patients With HAM/TSP

Objective: Human T-lymphotropic virus type-I-associated myelopathy / tropical spastic paraparesis (HAM/TSP) is a rare neurologic disorder that affects less tha…

United States750 participantsStarted 1998-04-06

All recent trials (37 shown)

Not Yet RecruitingPhase 2

NCT07555431

Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection

This phase 2b, open-label, randomized controlled trial evaluates the efficacy and safety of dolutegravir (DTG) alone versus dolutegravir combined with tenofovir…

Brazil146 participantsStarted 2026-04

Treatment: Combination of Dolutegravir + Tenofovir DF for treatment of HTLV-1 infection, Dolutegravir (DTG)

SuspendedPhase 1

NCT04301076

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for…

This phase I trial studies the side effects and best dose of lenalidomide when given together with usual combination chemotherapy (etoposide, prednisone, vincri…

United States30 participantsStarted 2021-08-31

Treatment:

HTLV-I Infection

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Evaluation of Patients With HAM/TSP

All recent trials (37 shown)

Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Evaluation of Patients With HAM/TSP

All recent trials (37 shown)

Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for…

Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Ch…

Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM)

Raltegravir for HAM/TSP

Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cance…

Notification of Donors With Positive Microbiology Markers

Rituximab for HTLV-1-associated Myelopathy

A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)

Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)

Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial

Rehabilitation in Patients With Human Lymphotropic Virus Type I

Electromiography Study in the Respiratory Muscle Training in Human Lymphotropic Virus Type 1

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection

Urological Physical Therapy in HTLV-1 With Urinary Symptoms

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma